SOX2 and glioblastoma: Since epigenetic regulations principally participate in self-renewal of stem cells, it could be possible that SOX2 expressions in CSCs are triggered by some epigenetic events as exemplified by frequent hypomethylation of SOX2 promoters in GBM patients due to deregulated methylation (Alonso et al., 2011).